GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
FUBP1
|
ENSG00000162613.12 | far upstream element binding protein 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FUBP1 | hg19_v2_chr1_-_78444776_78444800 | -0.23 | 7.1e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_91576429 | 12.25 |
ENST00000552145.1
ENST00000546745.1 |
DCN
|
decorin |
chr12_-_91576561 | 11.57 |
ENST00000547568.2
ENST00000552962.1 |
DCN
|
decorin |
chr1_-_182360918 | 10.09 |
ENST00000339526.4
|
GLUL
|
glutamate-ammonia ligase |
chr1_-_182360498 | 9.32 |
ENST00000417584.2
|
GLUL
|
glutamate-ammonia ligase |
chr11_-_33891362 | 8.74 |
ENST00000395833.3
|
LMO2
|
LIM domain only 2 (rhombotin-like 1) |
chr9_-_110251836 | 6.56 |
ENST00000374672.4
|
KLF4
|
Kruppel-like factor 4 (gut) |
chr3_-_112127981 | 5.50 |
ENST00000486726.2
|
RP11-231E6.1
|
RP11-231E6.1 |
chr2_+_113033164 | 4.74 |
ENST00000409871.1
ENST00000343936.4 |
ZC3H6
|
zinc finger CCCH-type containing 6 |
chr18_-_53255766 | 4.49 |
ENST00000566286.1
ENST00000564999.1 ENST00000566279.1 ENST00000354452.3 ENST00000356073.4 |
TCF4
|
transcription factor 4 |
chr12_+_57522258 | 4.21 |
ENST00000553277.1
ENST00000243077.3 |
LRP1
|
low density lipoprotein receptor-related protein 1 |
chr8_-_120685608 | 4.06 |
ENST00000427067.2
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
chr2_-_216300784 | 3.50 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
chr11_-_10590238 | 3.24 |
ENST00000256178.3
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
chr6_+_121756809 | 3.21 |
ENST00000282561.3
|
GJA1
|
gap junction protein, alpha 1, 43kDa |
chr3_-_187454281 | 2.94 |
ENST00000232014.4
|
BCL6
|
B-cell CLL/lymphoma 6 |
chr11_-_10590118 | 2.94 |
ENST00000529598.1
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
chr1_+_202317815 | 2.70 |
ENST00000608999.1
ENST00000336894.4 ENST00000480184.1 |
PPP1R12B
|
protein phosphatase 1, regulatory subunit 12B |
chr7_+_139529040 | 2.69 |
ENST00000455353.1
ENST00000458722.1 ENST00000411653.1 |
TBXAS1
|
thromboxane A synthase 1 (platelet) |
chr16_+_67381263 | 2.60 |
ENST00000541146.1
ENST00000563189.1 ENST00000290940.7 |
LRRC36
|
leucine rich repeat containing 36 |
chr7_+_139528952 | 2.57 |
ENST00000416849.2
ENST00000436047.2 ENST00000414508.2 ENST00000448866.1 |
TBXAS1
|
thromboxane A synthase 1 (platelet) |
chr9_+_82186682 | 2.48 |
ENST00000376552.2
|
TLE4
|
transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) |
chr14_+_61654271 | 2.42 |
ENST00000555185.1
ENST00000557294.1 ENST00000556778.1 |
PRKCH
|
protein kinase C, eta |
chr1_-_150738261 | 2.35 |
ENST00000448301.2
ENST00000368985.3 |
CTSS
|
cathepsin S |
chr12_+_10365404 | 2.28 |
ENST00000266458.5
ENST00000421801.2 ENST00000544284.1 ENST00000545047.1 ENST00000543602.1 ENST00000545887.1 |
GABARAPL1
|
GABA(A) receptor-associated protein like 1 |
chr9_+_82186872 | 2.28 |
ENST00000376544.3
ENST00000376520.4 |
TLE4
|
transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) |
chrX_-_65259900 | 2.26 |
ENST00000412866.2
|
VSIG4
|
V-set and immunoglobulin domain containing 4 |
chrX_-_65259914 | 2.22 |
ENST00000374737.4
ENST00000455586.2 |
VSIG4
|
V-set and immunoglobulin domain containing 4 |
chr4_-_16900242 | 2.21 |
ENST00000502640.1
ENST00000506732.1 |
LDB2
|
LIM domain binding 2 |
chr9_-_113761720 | 2.20 |
ENST00000541779.1
ENST00000374430.2 |
LPAR1
|
lysophosphatidic acid receptor 1 |
chr1_+_198608146 | 2.06 |
ENST00000367376.2
ENST00000352140.3 ENST00000594404.1 ENST00000598951.1 ENST00000530727.1 ENST00000442510.2 ENST00000367367.4 ENST00000348564.6 ENST00000367364.1 ENST00000413409.2 |
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
chr12_-_46766577 | 2.06 |
ENST00000256689.5
|
SLC38A2
|
solute carrier family 38, member 2 |
chr17_-_76713100 | 2.03 |
ENST00000585509.1
|
CYTH1
|
cytohesin 1 |
chr10_-_70092671 | 1.99 |
ENST00000358769.2
ENST00000432941.1 ENST00000495025.2 |
PBLD
|
phenazine biosynthesis-like protein domain containing |
chr4_-_100242549 | 1.94 |
ENST00000305046.8
ENST00000394887.3 |
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide |
chr19_+_18682661 | 1.86 |
ENST00000596273.1
ENST00000442744.2 ENST00000595683.1 ENST00000599256.1 ENST00000595158.1 ENST00000598780.1 |
UBA52
|
ubiquitin A-52 residue ribosomal protein fusion product 1 |
chr4_-_16900410 | 1.82 |
ENST00000304523.5
|
LDB2
|
LIM domain binding 2 |
chr7_+_116166331 | 1.77 |
ENST00000393468.1
ENST00000393467.1 |
CAV1
|
caveolin 1, caveolae protein, 22kDa |
chr15_-_34628951 | 1.70 |
ENST00000397707.2
ENST00000560611.1 |
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6 |
chr10_+_114710516 | 1.70 |
ENST00000542695.1
ENST00000346198.4 |
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box) |
chr14_-_24711865 | 1.69 |
ENST00000399423.4
ENST00000267415.7 |
TINF2
|
TERF1 (TRF1)-interacting nuclear factor 2 |
chr14_-_24711806 | 1.69 |
ENST00000540705.1
ENST00000538777.1 ENST00000558566.1 ENST00000559019.1 |
TINF2
|
TERF1 (TRF1)-interacting nuclear factor 2 |
chr16_+_28565230 | 1.64 |
ENST00000317058.3
|
CCDC101
|
coiled-coil domain containing 101 |
chr5_+_54320078 | 1.63 |
ENST00000231009.2
|
GZMK
|
granzyme K (granzyme 3; tryptase II) |
chr4_-_16900217 | 1.62 |
ENST00000441778.2
|
LDB2
|
LIM domain binding 2 |
chr2_+_33359687 | 1.59 |
ENST00000402934.1
ENST00000404525.1 ENST00000407925.1 |
LTBP1
|
latent transforming growth factor beta binding protein 1 |
chr4_-_16900184 | 1.57 |
ENST00000515064.1
|
LDB2
|
LIM domain binding 2 |
chr2_+_33359646 | 1.57 |
ENST00000390003.4
ENST00000418533.2 |
LTBP1
|
latent transforming growth factor beta binding protein 1 |
chr1_+_43766642 | 1.54 |
ENST00000372476.3
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
chr2_+_162087577 | 1.49 |
ENST00000439442.1
|
TANK
|
TRAF family member-associated NFKB activator |
chr2_+_201980827 | 1.43 |
ENST00000309955.3
ENST00000443227.1 ENST00000341222.6 ENST00000355558.4 ENST00000340870.5 ENST00000341582.6 |
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr19_-_19302931 | 1.37 |
ENST00000444486.3
ENST00000514819.3 ENST00000585679.1 ENST00000162023.5 |
MEF2BNB-MEF2B
MEF2BNB
MEF2B
|
MEF2BNB-MEF2B readthrough MEF2B neighbor myocyte enhancer factor 2B |
chr5_-_88179017 | 1.37 |
ENST00000514028.1
ENST00000514015.1 ENST00000503075.1 ENST00000437473.2 |
MEF2C
|
myocyte enhancer factor 2C |
chr4_-_89152474 | 1.34 |
ENST00000515655.1
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 |
chr7_+_74508372 | 1.32 |
ENST00000356115.5
ENST00000430511.2 ENST00000312575.7 |
GTF2IRD2B
|
GTF2I repeat domain containing 2B |
chrX_+_12924732 | 1.27 |
ENST00000218032.6
ENST00000311912.5 |
TLR8
|
toll-like receptor 8 |
chr7_-_74267836 | 1.21 |
ENST00000361071.5
ENST00000453619.2 ENST00000417115.2 ENST00000405086.2 |
GTF2IRD2
|
GTF2I repeat domain containing 2 |
chr5_-_88178964 | 1.18 |
ENST00000513252.1
ENST00000508569.1 ENST00000510942.1 ENST00000506554.1 |
MEF2C
|
myocyte enhancer factor 2C |
chr1_-_27701307 | 1.14 |
ENST00000270879.4
ENST00000354982.2 |
FCN3
|
ficolin (collagen/fibrinogen domain containing) 3 |
chr17_-_10421853 | 1.13 |
ENST00000226207.5
|
MYH1
|
myosin, heavy chain 1, skeletal muscle, adult |
chr4_-_25865159 | 1.11 |
ENST00000502949.1
ENST00000264868.5 ENST00000513691.1 ENST00000514872.1 |
SEL1L3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
chr12_+_14572070 | 1.09 |
ENST00000545769.1
ENST00000428217.2 ENST00000396279.2 ENST00000542514.1 ENST00000536279.1 |
ATF7IP
|
activating transcription factor 7 interacting protein |
chr17_-_8151353 | 1.00 |
ENST00000315684.8
|
CTC1
|
CTS telomere maintenance complex component 1 |
chr1_+_43855560 | 1.00 |
ENST00000562955.1
|
SZT2
|
seizure threshold 2 homolog (mouse) |
chr10_-_105845674 | 0.99 |
ENST00000353479.5
ENST00000369733.3 |
COL17A1
|
collagen, type XVII, alpha 1 |
chr5_-_160973649 | 0.98 |
ENST00000393959.1
ENST00000517547.1 |
GABRB2
|
gamma-aminobutyric acid (GABA) A receptor, beta 2 |
chr9_-_123812542 | 0.95 |
ENST00000223642.1
|
C5
|
complement component 5 |
chr12_+_56324756 | 0.93 |
ENST00000331886.5
ENST00000555090.1 |
DGKA
|
diacylglycerol kinase, alpha 80kDa |
chr5_-_1882858 | 0.93 |
ENST00000511126.1
ENST00000231357.2 |
IRX4
|
iroquois homeobox 4 |
chr7_+_96634850 | 0.90 |
ENST00000518156.2
|
DLX6
|
distal-less homeobox 6 |
chr3_-_170303845 | 0.88 |
ENST00000231706.5
|
SLC7A14
|
solute carrier family 7, member 14 |
chr13_-_26795840 | 0.83 |
ENST00000381570.3
ENST00000399762.2 ENST00000346166.3 |
RNF6
|
ring finger protein (C3H2C3 type) 6 |
chr1_-_216978709 | 0.83 |
ENST00000360012.3
|
ESRRG
|
estrogen-related receptor gamma |
chr5_+_137225158 | 0.82 |
ENST00000290431.5
|
PKD2L2
|
polycystic kidney disease 2-like 2 |
chr13_+_49551020 | 0.82 |
ENST00000541916.1
|
FNDC3A
|
fibronectin type III domain containing 3A |
chr6_+_167525277 | 0.82 |
ENST00000400926.2
|
CCR6
|
chemokine (C-C motif) receptor 6 |
chr11_+_64004888 | 0.81 |
ENST00000541681.1
|
VEGFB
|
vascular endothelial growth factor B |
chrX_-_55020511 | 0.80 |
ENST00000375006.3
ENST00000374992.2 |
PFKFB1
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
chr19_+_10765003 | 0.78 |
ENST00000407004.3
ENST00000589998.1 ENST00000589600.1 |
ILF3
|
interleukin enhancer binding factor 3, 90kDa |
chr14_+_75761099 | 0.77 |
ENST00000561000.1
ENST00000558575.1 |
RP11-293M10.5
|
RP11-293M10.5 |
chr15_-_88799948 | 0.74 |
ENST00000394480.2
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3 |
chr2_-_183291741 | 0.72 |
ENST00000351439.5
ENST00000409365.1 |
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent |
chr5_-_115872142 | 0.68 |
ENST00000510263.1
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
chrX_+_49644470 | 0.67 |
ENST00000508866.2
|
USP27X
|
ubiquitin specific peptidase 27, X-linked |
chrX_+_22056165 | 0.66 |
ENST00000535894.1
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked |
chr18_-_60986613 | 0.63 |
ENST00000444484.1
|
BCL2
|
B-cell CLL/lymphoma 2 |
chr12_-_57522813 | 0.61 |
ENST00000556155.1
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced |
chr1_-_115238207 | 0.59 |
ENST00000520113.2
ENST00000369538.3 ENST00000353928.6 |
AMPD1
|
adenosine monophosphate deaminase 1 |
chr19_-_45996465 | 0.59 |
ENST00000430715.2
|
RTN2
|
reticulon 2 |
chr18_-_60985914 | 0.59 |
ENST00000589955.1
|
BCL2
|
B-cell CLL/lymphoma 2 |
chr13_+_49684445 | 0.55 |
ENST00000398316.3
|
FNDC3A
|
fibronectin type III domain containing 3A |
chr1_-_161208013 | 0.54 |
ENST00000515452.1
ENST00000367983.4 |
NR1I3
|
nuclear receptor subfamily 1, group I, member 3 |
chr7_-_144533074 | 0.54 |
ENST00000360057.3
ENST00000378099.3 |
TPK1
|
thiamin pyrophosphokinase 1 |
chr10_-_65028817 | 0.51 |
ENST00000542921.1
|
JMJD1C
|
jumonji domain containing 1C |
chr7_-_144435985 | 0.50 |
ENST00000549981.1
|
TPK1
|
thiamin pyrophosphokinase 1 |
chr17_-_41739283 | 0.50 |
ENST00000393661.2
ENST00000318579.4 |
MEOX1
|
mesenchyme homeobox 1 |
chrX_-_33146477 | 0.49 |
ENST00000378677.2
|
DMD
|
dystrophin |
chr12_+_54366894 | 0.46 |
ENST00000546378.1
ENST00000243082.4 |
HOXC11
|
homeobox C11 |
chr4_-_101439242 | 0.46 |
ENST00000296420.4
|
EMCN
|
endomucin |
chr2_+_27435734 | 0.45 |
ENST00000419744.1
|
ATRAID
|
all-trans retinoic acid-induced differentiation factor |
chr7_-_124405681 | 0.45 |
ENST00000303921.2
|
GPR37
|
G protein-coupled receptor 37 (endothelin receptor type B-like) |
chr10_+_32856764 | 0.43 |
ENST00000375030.2
ENST00000375028.3 |
C10orf68
|
Homo sapiens coiled-coil domain containing 7 (CCDC7), transcript variant 5, mRNA. |
chr11_-_66964638 | 0.43 |
ENST00000444002.2
|
AP001885.1
|
AP001885.1 |
chr3_+_19988566 | 0.40 |
ENST00000273047.4
|
RAB5A
|
RAB5A, member RAS oncogene family |
chr11_+_111473108 | 0.39 |
ENST00000304987.3
|
SIK2
|
salt-inducible kinase 2 |
chr11_-_62752162 | 0.39 |
ENST00000458333.2
ENST00000421062.2 |
SLC22A6
|
solute carrier family 22 (organic anion transporter), member 6 |
chr4_+_170581213 | 0.38 |
ENST00000507875.1
|
CLCN3
|
chloride channel, voltage-sensitive 3 |
chr11_-_107590383 | 0.35 |
ENST00000525934.1
ENST00000531293.1 |
SLN
|
sarcolipin |
chr19_+_48969094 | 0.34 |
ENST00000595676.1
|
CTC-273B12.7
|
Uncharacterized protein |
chr11_+_112832090 | 0.33 |
ENST00000533760.1
|
NCAM1
|
neural cell adhesion molecule 1 |
chr8_-_20040638 | 0.32 |
ENST00000519026.1
ENST00000276373.5 ENST00000440926.1 ENST00000437980.1 |
SLC18A1
|
solute carrier family 18 (vesicular monoamine transporter), member 1 |
chr17_-_41738931 | 0.30 |
ENST00000329168.3
ENST00000549132.1 |
MEOX1
|
mesenchyme homeobox 1 |
chr1_+_171107241 | 0.29 |
ENST00000236166.3
|
FMO6P
|
flavin containing monooxygenase 6 pseudogene |
chr15_-_55657428 | 0.29 |
ENST00000568543.1
|
CCPG1
|
cell cycle progression 1 |
chr2_+_202122703 | 0.29 |
ENST00000447616.1
ENST00000358485.4 |
CASP8
|
caspase 8, apoptosis-related cysteine peptidase |
chr2_-_228497888 | 0.28 |
ENST00000264387.4
ENST00000409066.1 |
C2orf83
|
chromosome 2 open reading frame 83 |
chr4_-_48082192 | 0.28 |
ENST00000507351.1
|
TXK
|
TXK tyrosine kinase |
chr1_-_161207986 | 0.27 |
ENST00000506209.1
ENST00000367980.2 |
NR1I3
|
nuclear receptor subfamily 1, group I, member 3 |
chr12_+_120740119 | 0.25 |
ENST00000536460.1
ENST00000202967.4 |
SIRT4
|
sirtuin 4 |
chrX_+_22050546 | 0.22 |
ENST00000379374.4
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked |
chr11_-_62752455 | 0.22 |
ENST00000360421.4
|
SLC22A6
|
solute carrier family 22 (organic anion transporter), member 6 |
chr12_+_56324933 | 0.19 |
ENST00000549629.1
ENST00000555218.1 |
DGKA
|
diacylglycerol kinase, alpha 80kDa |
chr12_-_26986076 | 0.18 |
ENST00000381340.3
|
ITPR2
|
inositol 1,4,5-trisphosphate receptor, type 2 |
chr7_-_22233442 | 0.16 |
ENST00000401957.2
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
chr18_-_25616519 | 0.15 |
ENST00000399380.3
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal) |
chr5_+_156607829 | 0.12 |
ENST00000422843.3
|
ITK
|
IL2-inducible T-cell kinase |
chr11_-_62752429 | 0.11 |
ENST00000377871.3
|
SLC22A6
|
solute carrier family 22 (organic anion transporter), member 6 |
chr7_-_15601595 | 0.10 |
ENST00000342526.3
|
AGMO
|
alkylglycerol monooxygenase |
chr1_+_41157361 | 0.10 |
ENST00000427410.2
ENST00000447388.3 ENST00000425457.2 ENST00000453631.1 ENST00000456393.2 |
NFYC
|
nuclear transcription factor Y, gamma |
chr12_-_91451758 | 0.08 |
ENST00000266719.3
|
KERA
|
keratocan |
chr15_-_89764929 | 0.08 |
ENST00000268125.5
|
RLBP1
|
retinaldehyde binding protein 1 |
chr4_-_168155730 | 0.07 |
ENST00000502330.1
ENST00000357154.3 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
chr4_-_48136217 | 0.06 |
ENST00000264316.4
|
TXK
|
TXK tyrosine kinase |
chr5_+_140027355 | 0.06 |
ENST00000417647.2
ENST00000507593.1 ENST00000508301.1 |
IK
|
IK cytokine, down-regulator of HLA II |
chr1_-_244006528 | 0.06 |
ENST00000336199.5
ENST00000263826.5 |
AKT3
|
v-akt murine thymoma viral oncogene homolog 3 |
chr1_-_45140074 | 0.05 |
ENST00000420706.1
ENST00000372235.3 ENST00000372242.3 ENST00000372243.3 ENST00000372244.3 |
TMEM53
|
transmembrane protein 53 |
chr3_-_169587621 | 0.05 |
ENST00000523069.1
ENST00000316428.5 ENST00000264676.5 |
LRRC31
|
leucine rich repeat containing 31 |
chr17_-_77005860 | 0.04 |
ENST00000591773.1
ENST00000588611.1 ENST00000586916.2 ENST00000592033.1 ENST00000588075.1 ENST00000302345.2 ENST00000591811.1 |
CANT1
|
calcium activated nucleotidase 1 |
chr8_+_94929969 | 0.04 |
ENST00000517764.1
|
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
chr11_+_120207787 | 0.03 |
ENST00000397843.2
ENST00000356641.3 |
ARHGEF12
|
Rho guanine nucleotide exchange factor (GEF) 12 |
chr14_+_65878565 | 0.03 |
ENST00000556518.1
ENST00000557164.1 |
FUT8
|
fucosyltransferase 8 (alpha (1,6) fucosyltransferase) |
chr17_-_77005801 | 0.01 |
ENST00000392446.5
|
CANT1
|
calcium activated nucleotidase 1 |
chr19_+_11546093 | 0.00 |
ENST00000591462.1
|
PRKCSH
|
protein kinase C substrate 80K-H |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 19.4 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
2.2 | 6.6 | GO:0071409 | negative regulation of muscle hyperplasia(GO:0014740) cellular response to cycloheximide(GO:0071409) |
2.0 | 23.8 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.4 | 4.2 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
1.2 | 3.5 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
1.0 | 2.9 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.8 | 3.2 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
0.6 | 2.5 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.6 | 3.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.6 | 1.8 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.6 | 3.4 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.5 | 2.2 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.5 | 2.0 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.4 | 11.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.4 | 3.2 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.3 | 2.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 2.1 | GO:0032328 | alanine transport(GO:0032328) |
0.3 | 1.7 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.3 | 1.3 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.3 | 0.9 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.3 | 4.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.3 | 1.2 | GO:0043375 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
0.3 | 5.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.3 | 1.7 | GO:0044334 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.3 | 7.2 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.3 | 0.8 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.3 | 0.8 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.3 | 1.0 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.2 | 1.5 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.2 | 0.7 | GO:0052026 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.2 | 0.7 | GO:0097254 | renal tubular secretion(GO:0097254) |
0.2 | 1.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 6.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.2 | 0.8 | GO:0061056 | somite specification(GO:0001757) sclerotome development(GO:0061056) |
0.2 | 4.5 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.2 | 1.9 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.2 | 0.9 | GO:1904383 | response to sodium phosphate(GO:1904383) |
0.2 | 0.3 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.2 | 1.0 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.2 | 0.6 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.1 | 1.4 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 2.3 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 1.3 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.8 | GO:1903301 | fructose 2,6-bisphosphate metabolic process(GO:0006003) positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.4 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.1 | 1.9 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.1 | 2.0 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 4.8 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.1 | 0.3 | GO:0052148 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
0.1 | 0.3 | GO:0015888 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
0.1 | 0.8 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.4 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 1.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.5 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 0.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.6 | GO:0032264 | IMP salvage(GO:0032264) |
0.1 | 0.3 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.0 | 1.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.0 | 1.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.5 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.0 | 0.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 1.5 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 1.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 1.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.5 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.0 | 0.7 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.5 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.1 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.0 | 0.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.8 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 3.1 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.9 | GO:0009798 | axis specification(GO:0009798) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 23.8 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
1.0 | 19.4 | GO:0097386 | glial cell projection(GO:0097386) |
0.7 | 3.4 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.3 | 2.3 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.3 | 1.7 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.3 | 3.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 3.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 6.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 1.0 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 3.2 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 1.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.9 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 1.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) ripoptosome(GO:0097342) |
0.1 | 1.2 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.6 | GO:0014802 | terminal cisterna(GO:0014802) |
0.1 | 2.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 1.3 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.1 | 1.0 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 0.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 1.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 1.9 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.5 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 22.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.4 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.0 | 4.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 3.4 | GO:0031672 | A band(GO:0031672) |
0.0 | 2.9 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 0.3 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.0 | 1.0 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 1.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 1.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 2.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 1.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 1.7 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.2 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.0 | 3.4 | GO:0045121 | membrane raft(GO:0045121) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 19.4 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
1.8 | 5.3 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
1.3 | 6.6 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
1.1 | 4.2 | GO:0042954 | apolipoprotein receptor activity(GO:0030226) lipoprotein transporter activity(GO:0042954) |
1.0 | 4.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.7 | 7.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.6 | 3.2 | GO:0050436 | microfibril binding(GO:0050436) |
0.6 | 1.8 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.5 | 3.2 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.5 | 2.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.4 | 26.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.3 | 4.5 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.3 | 1.9 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.3 | 0.8 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.2 | 1.5 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.2 | 2.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 6.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 2.9 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 8.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 3.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 1.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.2 | 2.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 0.8 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 1.7 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 1.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.1 | 0.8 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.1 | 1.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.8 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 1.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 1.8 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.3 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) |
0.1 | 1.0 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 3.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 2.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 3.5 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.7 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.7 | GO:1990380 | Lys63-specific deubiquitinase activity(GO:0061578) Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.6 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.4 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.1 | 0.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.3 | GO:0047708 | biotinidase activity(GO:0047708) |
0.1 | 1.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 1.6 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 1.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.7 | GO:0005030 | GPI-linked ephrin receptor activity(GO:0005004) neurotrophin receptor activity(GO:0005030) |
0.0 | 0.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.5 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 2.2 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.0 | 3.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 1.5 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.9 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 2.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.0 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 2.0 | GO:0016853 | isomerase activity(GO:0016853) |
0.0 | 2.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 24.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 7.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 17.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 2.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 4.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 3.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 2.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 2.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 2.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 2.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 1.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 1.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 1.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 3.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.5 | PID FGF PATHWAY | FGF signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 23.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.7 | 19.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.4 | 6.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 6.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 3.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 1.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 1.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 3.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 8.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 3.5 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 1.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 2.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 3.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 5.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 2.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 3.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 4.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 1.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 1.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 1.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.9 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 1.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 1.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.6 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |